FY2017 Earnings Estimate for Cigna Corporation Issued By Leerink Swann (CI)

Cigna Corporation (NYSE:CI) – Stock analysts at Leerink Swann lifted their FY2017 earnings per share (EPS) estimates for shares of Cigna Corporation in a report issued on Friday. Leerink Swann analyst A. Gupte now forecasts that the health services provider will earn $10.40 per share for the year, up from their prior forecast of $10.05. Leerink Swann also issued estimates for Cigna Corporation’s Q4 2017 earnings at $1.89 EPS and FY2018 earnings at $11.50 EPS.

Cigna Corporation (NYSE:CI) last posted its quarterly earnings data on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, topping the consensus estimate of $2.36 by $0.47. The firm had revenue of $10.38 billion during the quarter, compared to analyst estimates of $10.17 billion. Cigna Corporation had a return on equity of 18.85% and a net margin of 5.74%. Cigna Corporation’s revenue was up 5.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.94 EPS. WARNING: This news story was first reported by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another site, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The correct version of this news story can be viewed at https://www.com-unik.info/2017/11/06/fy2017-earnings-estimate-for-cigna-corporation-issued-by-leerink-swann-ci.html.

Several other equities research analysts have also commented on the company. Citigroup Inc. upped their price objective on Cigna Corporation from $198.00 to $231.00 and gave the stock a “buy” rating in a research note on Friday. Morgan Stanley upped their price objective on Cigna Corporation from $195.00 to $223.00 and gave the stock an “overweight” rating in a research note on Friday. Jefferies Group LLC upped their price objective on Cigna Corporation from $221.00 to $231.00 and gave the stock a “buy” rating in a research note on Friday. Royal Bank Of Canada restated an “outperform” rating and issued a $220.00 price objective (up from $185.00) on shares of Cigna Corporation in a research note on Friday. Finally, Credit Suisse Group began coverage on Cigna Corporation in a research note on Thursday. They issued an “outperform” rating and a $219.00 price objective for the company. Two research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $201.50.

Shares of Cigna Corporation (NYSE:CI) opened at $201.90 on Monday. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.39 and a quick ratio of 0.39. The company has a market capitalization of $49,778.38, a P/E ratio of 19.45, a price-to-earnings-growth ratio of 1.49 and a beta of 0.49.

In other Cigna Corporation news, insider Michael W. Triplett sold 3,700 shares of the stock in a transaction dated Tuesday, August 8th. The shares were sold at an average price of $174.96, for a total transaction of $647,352.00. Following the completion of the transaction, the insider now owns 21,060 shares of the company’s stock, valued at approximately $3,684,657.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Isaiah Harris, Jr. sold 247 shares of the stock in a transaction dated Tuesday, September 12th. The shares were sold at an average price of $185.27, for a total transaction of $45,761.69. The disclosure for this sale can be found here. Insiders sold a total of 7,940 shares of company stock valued at $1,419,384 in the last ninety days. 1.30% of the stock is currently owned by insiders.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Wetherby Asset Management Inc. boosted its holdings in shares of Cigna Corporation by 0.8% during the 2nd quarter. Wetherby Asset Management Inc. now owns 4,192 shares of the health services provider’s stock valued at $702,000 after purchasing an additional 33 shares during the last quarter. Cadence Capital Management LLC boosted its holdings in shares of Cigna Corporation by 0.3% during the 2nd quarter. Cadence Capital Management LLC now owns 9,598 shares of the health services provider’s stock valued at $1,607,000 after purchasing an additional 33 shares during the last quarter. Winslow Evans & Crocker Inc. boosted its holdings in shares of Cigna Corporation by 1.9% during the 2nd quarter. Winslow Evans & Crocker Inc. now owns 1,814 shares of the health services provider’s stock valued at $304,000 after purchasing an additional 34 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Cigna Corporation by 2.3% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,760 shares of the health services provider’s stock valued at $295,000 after purchasing an additional 40 shares during the last quarter. Finally, Veritable L.P. boosted its holdings in shares of Cigna Corporation by 0.5% during the 2nd quarter. Veritable L.P. now owns 8,220 shares of the health services provider’s stock valued at $1,376,000 after purchasing an additional 41 shares during the last quarter. 88.16% of the stock is owned by institutional investors and hedge funds.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Earnings History and Estimates for Cigna Corporation (NYSE:CI)

What are top analysts saying about Cigna Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cigna Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit